The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
11 hedge funds and large institutions have $536K invested in The Oncology Institute Warrant in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.44% more ownership
Funds ownership: 0% → 1.44% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
+$89.7K |
| 2 |
MCM
Moore Capital Management
New York
|
+$89.7K |
| 3 |
JG
Jefferies Group
New York
|
+$71.9K |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$71.7K |
| 5 |
OCAM
Owl Creek Asset Management
New York
|
+$71.7K |
Top Sellers
TOIIW Hedge Fund Activity: Q2 2020 in Review
11 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q2 2020, worth a combined $536K.
Buyers outnumbered sellers: 11 funds opened new TOIIW positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fir Tree Capital Management, opening a new position worth an estimated $89.7K.
- 11 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $536K of The Oncology Institute Warrant stock for Q2 2020.
- 11 funds opened new The Oncology Institute Warrant positions in Q2 2020 and 0 closed out, a net change of +11 holders.
- The largest The Oncology Institute Warrant buyer in Q2 2020 was Fir Tree Capital Management, an estimated $89.7K added.
Based on aggregated 13F filings for Q2 2020.